Acadia Pharmaceuticals ACAD Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Acadia Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Acadia Pharmaceuticals's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Acadia Pharmaceuticals's gross margin?
- Acadia Pharmaceuticals (ACAD) reported gross margin of 91.5% in Q1 2026.
- How has Acadia Pharmaceuticals's gross margin changed year-over-year?
- Acadia Pharmaceuticals's gross margin decreased by 0.6% year-over-year, from 92% to 91.5%.
- What is the long-term trend for Acadia Pharmaceuticals's gross margin?
- Over 5 years (2020 to 2025), Acadia Pharmaceuticals's gross margin has grown at a -1.3% compound annual growth rate (CAGR), from 97.7% to 91.7%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.